Enfusion (ENFN) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free ENFN Stock Alerts $9.67 +0.03 (+0.31%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | americanbankingnews.comEnfusion (NYSE:ENFN) Research Coverage Started at Morgan StanleyMay 13, 2024 | finance.yahoo.comEnfusion, Inc. (NYSE:ENFN) Q1 2024 Earnings Call TranscriptMay 13, 2024 | seekingalpha.comEnfusion, Inc. (ENFN) Q1 2024 Earnings Call TranscriptMay 11, 2024 | finance.yahoo.comEnfusion First Quarter 2024 Earnings: EPS Misses ExpectationsMay 10, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Issues Quarterly Earnings Results, Misses Estimates By $0.05 EPSEnfusion (NYSE:ENFN - Get Free Report) released its earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Enfusion had a net margin of 3.45% and a return on equity of 10.30%. The company had revenue of $48.05 million during the quarter, compared to analysts' expectations of $47.67 million. During the same quarter last year, the business posted $0.04 earnings per share.May 10, 2024 | marketbeat.comMorgan Stanley Begins Coverage on Enfusion (NYSE:ENFN)Morgan Stanley began coverage on Enfusion in a research note on Friday. They issued an "overweight" rating and a $11.00 target price on the stock.May 9, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Shares Down 7.3% Enfusion (NYSE:ENFN) Trading Down 7.3%May 9, 2024 | msn.comENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comEnfusion Announces First Quarter 2024 ResultsMay 7, 2024 | finance.yahoo.comHas Enfusion, Inc.'s (NYSE:ENFN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?April 18, 2024 | businesswire.comEnfusion Announces Date of First Quarter 2024 ResultsApril 17, 2024 | morningstar.comEnfusion Inc Class AApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNApril 12, 2024 | marketbeat.comVanguard Group Inc. Purchases 512,479 Shares of Enfusion, Inc. (NYSE:ENFN)Vanguard Group Inc. boosted its holdings in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 17.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,487,815 shares of the company's stockApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNApril 4, 2024 | msn.comThe 3 Most Undervalued Under-$10 Stocks to Buy in April 2024April 2, 2024 | finance.yahoo.comWill Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?April 2, 2024 | businesswire.comConnexPay Appoints Ben Peters as Chief Executive OfficerMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNMarch 22, 2024 | markets.businessinsider.comEnfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic ChallengesMarch 21, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)March 20, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)March 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNMarch 18, 2024 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Receives Consensus Recommendation of "Reduce" from AnalystsEnfusion, Inc. (NYSE:ENFN - Get Free Report) has earned an average rating of "Reduce" from the six analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has issued a buy recMarch 15, 2024 | markets.businessinsider.comWall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024March 15, 2024 | marketbeat.comBrokers Set Expectations for Enfusion, Inc.'s Q1 2025 Earnings (NYSE:ENFN)Enfusion, Inc. (NYSE:ENFN - Free Report) - Equities research analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Enfusion in a note issued to investors on Tuesday, March 12th. William Blair analyst D. Becker anticipates that the company will post earninMarch 14, 2024 | seekingalpha.comEnfusion, Inc. (ENFN) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Shares Gap Down to $9.32Enfusion (NYSE:ENFN) Shares Gap Down to $9.32March 14, 2024 | finance.yahoo.comEnfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)March 12, 2024 | markets.businessinsider.comWilliam Blair Reaffirms Their Buy Rating on Enfusion (ENFN)March 12, 2024 | msn.comEnfusion reports mixed Q4 results; initiates FY24 outlookMarch 12, 2024 | finance.yahoo.comEnfusion Announces Fourth Quarter 2023 Results and Full Year 2023 ResultsMarch 11, 2024 | benzinga.comEarnings Outlook For EnfusionMarch 6, 2024 | benzinga.comMajor Purchase Alert: Oleg Movchan Invests $120K In Enfusion StockMarch 5, 2024 | marketbeat.comEnfusion (ENFN) Scheduled to Post Earnings on TuesdayEnfusion (NYSE:ENFN) will be releasing earnings before the market opens on Tuesday, March 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=567119)February 29, 2024 | msn.comGoldman Sachs Downgrades Enfusion (ENFN)February 28, 2024 | msn.comEnfusion stock retreats after Goldman downgrades to SellFebruary 28, 2024 | markets.businessinsider.comEnfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges AheadFebruary 28, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Cut to Sell at The Goldman Sachs GroupThe Goldman Sachs Group cut Enfusion from a "neutral" rating to a "sell" rating and decreased their price objective for the stock from $9.00 to $8.00 in a research note on Wednesday.February 20, 2024 | msn.comArteris, Inc. (AIP) Reports Q4 Loss, Tops Revenue EstimatesFebruary 17, 2024 | nasdaq.comEnfusion Breaks Above 200-Day Moving Average - Bullish for ENFNFebruary 13, 2024 | finance.yahoo.comEnfusion Announces Date of Fourth Quarter and Full Year 2023 ResultsFebruary 12, 2024 | finance.yahoo.comEnfusion to Host Investor Day on March 19, 2024February 8, 2024 | bizjournals.comTrust of tech CEO sells Boca Raton mansion for $29 millionFebruary 7, 2024 | marketbeat.comNew York State Common Retirement Fund Boosts Stock Position in Enfusion, Inc. (NYSE:ENFN)New York State Common Retirement Fund increased its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 17.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,618,803 shares of the cJanuary 30, 2024 | marketbeat.comEnfusion (NYSE:ENFN) Shares Gap Down to $8.50Enfusion (NYSE:ENFN) Shares Gap Down to $8.50January 30, 2024 | realmoney.thestreet.comEnfusion downgraded to Underweight on client risks at JPMorganJanuary 30, 2024 | markets.businessinsider.comJP Morgan Downgrades Enfusion: Here's What You Need To KnowJanuary 30, 2024 | realmoney.thestreet.comJPMorgan gets more bearish on Enfusion, downgrades shares Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. ENFN Media Mentions By Week ENFN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENFN News Sentiment▼0.450.46▲Average Computer and Technology News Sentiment ENFN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENFN Articles This Week▼42▲ENFN Articles Average Week Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DCBO News OPRA News FSLY News PDFS News BASE News VTEX News TUYA News EVBG News ZUO News MOMO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENFN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
